Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...
pharmaphorum6d
Regeneron, Illumina join $320m Truveta investment
Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...
STAT16d
Truveta enlists health systems, drugmakers to launch ambitious new genomic database
Health data company Truveta said Monday it’s partnering with health systems and drugmakers to launch the Truveta Genome Project, a database of genetic data that is expected to accelerate ...
AOL13d
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
Those data will join Regeneron’s existing DNA sequence-linked health care database of nearly 3 million people. Part of the company’s interest in joining the Truveta Genome Project was the ...
Yahoo News UK13d
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
Truveta, a health data startup launched in 2020, announced the massive undertaking Jan. 13 along with biotech firm Illumina and the Regeneron Genetics Center, an arm of Fortune 500 company Regeneron ...
HealthLeaders Media7d
Investing in Innovation: Health Systems Put Millions Into Truveta Genome Project
Seventeen health systems are investing in a genomic database that could significantly drive down clinical costs. Truveta, a Washington-based software company, unveiled the Truveta Genome Project on ...
Nasdaq16d
Regeneron and Truveta Announce Strategic Collaboration for the Truveta Genome Project, Aiming to Expand Genetic Database and Accelerate Drug Discovery
Regeneron collaborates with Truveta to expand a genomic database, investing $119.5 million to enhance genetics-based healthcare research. Regeneron's $119.5 million investment in Truveta's Series ...
Truveta sells stakes to Regeneron, Illumina in deal to build genetic database
Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will take a $320 million stake in the company as part of a deal to build the ...